Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study in the Safety and Efficacy of Transduced Keratinocytes for Possible Treatment of Gyrate Atrophy

NCT00001735 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT00001735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study in the Safety and Efficacy of Transduced Keratinocytes for Possible Treatment of Gyrate Atrophy
Lead sponsor
National Eye Institute (NEI)
Phase
Phase 1
Overall status
Completed
Start date
April 30, 1998
Completion date
October 31, 2000
Enrollment
5
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gyrate atrophy